Search Results - "Tarasiuk, Jolanta"

Refine Results
  1. 1

    Antitumour Effects of Selected Pyridinium Salts on Sensitive Leukaemia HL60 Cells and Their Multidrug Resistant Topoisomerase II-Defective HL60/MX2 Counterparts by Tarasiuk, Jolanta, Kostrzewa-Nowak, Dorota, Żwierełło, Wojciech

    Published in Molecules (Basel, Switzerland) (01-08-2022)
    “…Multidrug resistance (MDR), having a multifactorial nature, is one of the major clinical problems causing the failure of anticancer therapy. The aim of this…”
    Get full text
    Journal Article
  2. 2

    In vitro antileukaemic activity of extracts from berry plant leaves against sensitive and multidrug resistant HL60 cells by Skupień, Katarzyna, Oszmiański, Jan, Kostrzewa-Nowak, Dorota, Tarasiuk, Jolanta

    Published in Cancer letters (18-05-2006)
    “…The aim of the present study was to determine in vitro antileukaemic activity of extracts obtained from selected berry plant leaves ( Fragaria x ananassa Duch…”
    Get full text
    Journal Article
  3. 3

    Antitumour effects of selected plant polyphenols, gallic acid and ellagic acid, on sensitive and multidrug‐resistant leukaemia HL60 cells by Maruszewska, Agnieszka, Tarasiuk, Jolanta

    Published in Phytotherapy research (01-04-2019)
    “…The aim of this study was to examine the antitumour effects of plant phenolic acids, gallic acid (GA) and ellagic acid (EA), on human promyelocytic leukaemia…”
    Get full text
    Journal Article
  4. 4

    Quercetin Triggers Induction of Apoptotic and Lysosomal Death of Sensitive and Multidrug Resistant Leukaemia HL60 Cells by Maruszewska, Agnieszka, Tarasiuk, Jolanta

    Published in Nutrition and cancer (2021)
    “…Multidrug resistance (MDR) constitutes the major cause of the failure in anticancer therapy. One of the most important mechanisms leading to the occurrence of…”
    Get full text
    Journal Article
  5. 5

    Bioreductive Activation of Antitumour Drugs, Doxorubicin and Pirarubicin, Does Not Affect Their Ability to Induce Apoptosis of Sensitive and Multidrug Resistant Leukaemia HL60 Cells by Kostrzewa-Nowak, Dorota, Tarasiuk, Jolanta

    Published in Anticancer research (01-03-2021)
    “…Clinical significance of antitumour drugs is limited by multidrug resistance (MDR). We examined the effect of bioreductive activation of the anthracyclines,…”
    Get full text
    Journal Article
  6. 6

    Comparative effects of selected plant polyphenols, gallic acid and epigallocatechin gallate, on matrix metalloproteinases activity in multidrug resistant MCF7/DOX breast cancer cells by Nowakowska, Anna, Tarasiuk, Jolanta

    Published in Acta biochimica Polonica (01-01-2016)
    “…The aim of the study was to investigate the effect of selected polyphenols: gallic acid (GA) and epigallocatechin gallate (EGCG) on matrix metalloproteinase…”
    Get full text
    Journal Article
  7. 7

    Invasion and metastasis of tumour cells resistant to chemotherapy by Nowakowska, Anna, Tarasiuk, Jolanta

    “…Metastatic tumours resistant to chemotherapy are the major cause of the clinical failure in the treatment of malignant diseases. It is observed often that…”
    Get full text
    Journal Article
  8. 8

    Retaining cytotoxic activity of anthrapyridone CO1 against multidrug resistant cells is related to the ability to induce concomitantly apoptosis and lysosomal death of leukaemia HL60/VINC and HL60/DOX cells by Nowak, Robert, Tarasiuk, Jolanta

    Published in Journal of pharmacy and pharmacology (01-06-2013)
    “…Objectives The effect of anthrapyridone compound CO1 retaining cytotoxic activity against multidrug resistant (MDR) tumour cells on inducing cell death of the…”
    Get full text
    Journal Article
  9. 9

    Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells by Kostrzewa-Nowak, Dorota, Tarasiuk, Jolanta

    Published in European journal of pharmacology (05-12-2013)
    “…The objective of this study was to examine the effect of bioreductive activation of antitumour drug, mitoxantrone (MX), by liver NADPH cytochrome P450…”
    Get full text
    Journal Article
  10. 10

    DNA damage induced by NADPH cytochrome P450 reductase-activated idarubicin in sensitive and multidrug resistant MCF7 breast cancer cells by Żwierełło, Wojciech, Maruszewska, Agnieszka, Nowak, Robert, Kostrzewa-Nowak, Dorota, Tarasiuk, Jolanta

    Published in Pharmacological reports (01-02-2017)
    “…Idarubicin (IDA) is one of clinically important anticancer drugs belonging to the anthracycline antibiotic family. The aim of this study was to examine DNA…”
    Get more information
    Journal Article
  11. 11

    Anthraquinone antitumour agents, doxorubicin, pirarubicin and benzoperimidine BP1, trigger caspase-3/caspase-8-dependent apoptosis of leukaemia sensitive HL60 and resistant HL60/VINC and HL60/DOX cells by Nowak, Robert, Tarasiuk, Jolanta

    Published in Anti-cancer drugs (01-04-2012)
    “…We examined the effect of selected anthraquinone antitumour agents – doxorubicin (DOX), pirarubicin (PIRA) and benzoperimidine BP1 – on inducing apoptosis of…”
    Get full text
    Journal Article
  12. 12

    In vitro antileukaemic activity of extracts from chokeberry (Aronia melanocarpa [Michx] Elliott) and mulberry (Morus alba L.) leaves against sensitive and multidrug resistant HL60 cells by Skupień, Katarzyna, Kostrzewa-Nowak, Dorota, Oszmiański, Jan, Tarasiuk, Jolanta

    Published in Phytotherapy research (01-05-2008)
    “…The aim of the present study was to determine in vitro antileukaemic activities of extracts obtained from chokeberry (Aronia melanocarpa [Michx] Elliot) and…”
    Get full text
    Journal Article
  13. 13

    The role of bioreductive activation of antitumour anthracycline drugs in cytotoxic activity against sensitive and multidrug resistant leukaemia HL60 cells by Kostrzewa-Nowak, Dorota, Bieg, Bohdan, Paine, Mark J.I., Wolf, C. Roland, Tarasiuk, Jolanta

    Published in European journal of pharmacology (15-01-2012)
    “…Clinical usefulness of anthracyclines belonging to bioreductive antitumour drugs is limited by the occurrence of multidrug resistance (MDR). The aim of this…”
    Get full text
    Journal Article
  14. 14

    Effect of selected NAD + analogues on mitochondria activity and proliferation of endothelial EA.hy926 cells by Nowak, Robert, Wrzosek, Antoni, Łukasiak, Agnieszka, Rutkowska, Magdalena, Adamus, Jan, Gębicki, Jerzy, Dołowy, Krzysztof, Szewczyk, Adam, Tarasiuk, Jolanta

    Published in European journal of pharmacology (25-08-2010)
    “…The aim of the study was to examine the effect of 1-methylnicotinamide (MNA) and 1-methyl-3-nitropyridine (MNP) on mitochondria activity and proliferation of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Molecular basis of the low activity of antitumor anthracenediones, mitoxantrone and ametantrone, in oxygen radical generation catalyzed by NADH dehydrogenase. Enzymatic and molecular modelling studies by Tarasiuk, Jolanta, Mazerski, Jan, Tkaczyk-Gobis, Katarzyna, Borowski, Edward

    Published in European journal of medicinal chemistry (01-04-2005)
    “…Synthetic antitumor anthracenedione drugs, in contrast to anthracycline antibiotics, are ineffective in free radical formation in NADH dehydrogenase system…”
    Get full text
    Journal Article
  19. 19

    The purine nucleotide content in human leukemia cell lines by Baranowska-Bosiacka, Irena, Machaliński, Bogusław, Tarasiuk, Jolanta

    “…The HPLC method was used to determine the purine nucleotide (ATP, ADP, AMP, GTP, GDP, GMP, NAD(+)) contents and the values of the adenylate energy charge (AEC)…”
    Get more information
    Journal Article
  20. 20

    The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines by Tarasiuk, Jolanta, Majewska, Ewelina, Seksek, Olivier, Rogacka, Dorota, Antonini, Ippolito, Garnier-Suillerot, Arlette, Borowski, Edward

    Published in Biochemical pharmacology (01-11-2004)
    “…The appearance of multidrug resistance (MDR) of tumour cells to a wide array of antitumour drugs, structurally diverse and having different mechanisms of…”
    Get full text
    Journal Article